Article
Oklahoma City - Results of preclinical and initial clinical studies indicate the investigational compound CX-452 has promising activity as a highly safe and very effective topical nonsteroidal anti-inflammatory and anti-aging agent, Bryan B. Fuller, Ph.D., said.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.